The record
Every material change on record
124 material regulatory changes — state legislation, FDA enforcement and compounding actions, and FTC advertising cases. The live feed shows the last 18 months; this is everything, permanently. Each entry links to its own page and, from there, to the primary source.
Background records — single-shipment border refusals and routine facility citations — are on the feed but not here. They are on the record and they are not things a practice acts on; mixing them in would bury the changes that are.
2026 · 94 changes
- Oct 1, 2026FederalPrimary Source Monitoring: Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
- Oct 1, 2026WashingtonWA State Health Agency: Withdrawal of Allopathic Physicians and Physician Assistants – Collaborative Drug Therapy Agreements
- Sep 30, 2026FederalPrimary Source Monitoring: Dauphin County Man Ordered To Forfeit $180,000 For Distributing Misbranded Drugs And Money Laundering
- Sep 29, 2026District of ColumbiaDC B26-0833: Health Occupations and Emergency Medical Services Amendment Act of 2026
- Sep 28, 2026WisconsinWI State Administrative Register: 849B Register (9/28/2026) - 2026-09-28
- Sep 25, 2026UtahUT State Licensing Agency: 2026 Periodic Review: Anesthesiologist Assistants
- Sep 21, 2026FederalPrimary Source Monitoring: Otsuka Icu Medical LLC Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection, USP Due To a Product Mix-up with 10 mEq Potassium Chlori…
- Sep 21, 2026FederalPrimary Source Monitoring: Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate…
- Sep 21, 2026FederalPrimary Source Monitoring: Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
- Sep 21, 2026WisconsinWI State Administrative Register: 849A3 Register (9/21/2026) - 2026-09-21
- Sep 17, 2026FederalPrimary Source Monitoring: Korea Filler Experts - 718706 - 11/03/2025
- Sep 16, 2026FederalFDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
- Sep 16, 2026FederalPrimary Source Monitoring: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
- Sep 15, 2026FederalPrimary Source Monitoring: Hefner v. Rock Valley Compounding Pharmacy, LLC (3:26-cv-01298) — District Court, S.D. Illinois
- Sep 14, 2026WisconsinWI State Administrative Register: 849A2 Register (9/14/2026) - 2026-09-14
- Sep 9, 2026FederalPrimary Source Monitoring: Human Drug Compounding Policies and Rules
- Sep 4, 2026FederalPrimary Source Monitoring: Eli Lilly v. Instant Rx (E.D.N.Y.) — Consent Judgment and Permanent Injunction as to defendants Dispensing Physician Consultants, Inc. d/b/a Ira's Di…
- Sep 4, 2026FederalPrimary Source Monitoring: Med Spa Owner Sentenced to 46 Months in Prison for Performing Thousands of Counterfeit Botox and Filler Injections
- Sep 3, 2026WashingtonWA State Health Agency: Registered Nurse (RN) and Licensed Practical Nurse (Lpn) Licensing Requirements
- Sep 1, 2026FederalPrimary Source Monitoring: Peak Performance Peptides - 735127 - 08/24/2026
- Aug 31, 2026WisconsinWI State Administrative Register: 848B Register (8/31/2026) - 2026-08-31
- Aug 28, 2026FederalPrimary Source Monitoring: Agency Information Collection Activities; Proposals, Submissions, and Approvals: Registration of Human Drug Compounding Outsourcing Facilities Under …
- Aug 28, 2026WisconsinWI State Administrative Register: Register 848 - Removed Chapter Sps 382 - 2026-08-28
- Aug 28, 2026WisconsinWI State Administrative Register: Register 848 - Inserted Chapter Sps 382 - 2026-08-28
- Aug 26, 2026OhioOH HB377: Regards use of light-based medical devices for hair removal
- Aug 25, 2026FederalFDA Warning Letter: Advance-Esthetic LLC (Devices)
- Aug 25, 2026FederalPrimary Source Monitoring: Drug Shortages | Additional News and Information
- Aug 24, 2026FederalFDA Warning Letter: Royal Peptides LLC (Drugs)
- Aug 24, 2026FederalFDA Warning Letter: Peptide Partners, LLC (Drugs)
- Aug 24, 2026FederalFDA Warning Letter: Peak Performance Peptides (Drugs)
- Aug 21, 2026FederalPrimary Source Monitoring: Compounding Information for States
- Aug 21, 2026FederalPrimary Source Monitoring: Compounding and the FDA: Questions and Answers
- Aug 19, 2026FederalFDA recall (Class II): Semaglutide 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, Apollo care, …
- Aug 17, 2026FederalPrimary Source Monitoring: Illinois Man Charged With Scheme To Impersonate Doctors And Make False Statements To Obtain GLP-1 Medications
- Aug 12, 2026FederalPrimary Source Monitoring: Eli Lilly and Company v. Lone Star Peptide Co. LLC (4:26-cv-06562) — District Court, S.D. Texas
- Aug 10, 2026WisconsinWI State Administrative Register: Emergency Rules Filed with Legislative Reference Bureau - 2026-08-10
- Aug 7, 2026IllinoisIL HB5000: Health Facilities Planning
- Aug 3, 2026WisconsinWI State Administrative Register: 848A1 Register (8/3/2026) - 2026-08-03
- Jul 31, 2026FederalPrimary Source Monitoring: Illinois Man and Indiana Woman Sentenced Respectively to 70 Months and 16 Months in Prison For Selling Unapproved Drugs in Interstate Commerce
- Jul 30, 2026FederalFDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
- Jul 17, 2026FederalPrimary Source Monitoring: Wilson v. Lexington Compounding Pharmacy, Inc. (5:26-cv-00273) — District Court, E.D. Kentucky
- Jul 8, 2026FederalFDA Warning Letter: Spa De Soleil, Inc. (Drugs)
- Jul 1, 2026FederalPrimary Source Monitoring: Massachusetts Couple Sentenced to Prison for Importing Misbranded Drugs From China and Selling Them to Customers in U.S. for Performance Enhancing Pu…
- Jun 29, 2026FederalPrimary Source Monitoring: Pagan v. Glow Med Spa (1:26-cv-24474) — District Court, S.D. Florida
- Jun 26, 2026FederalFDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
- Jun 25, 2026AlabamaAL Primary Source Monitoring: Proposed Rule Changes
- Jun 23, 2026FederalFDA Warning Letter: ketaminelab.org (Drugs)
- Jun 17, 2026FederalFDA Warning Letter: Herbal Dermals LLC Fz (Drugs)
- Jun 17, 2026FederalFDA Warning Letter: Herbal Dermals Ltd (Drugs)
- Jun 17, 2026FederalFDA Warning Letter: Herbal Dermals Ltd (Drugs)
- Jun 17, 2026FederalFDA Warning Letter: Wholesale Peptide (Drugs)
- Jun 17, 2026FederalFDA Warning Letter: Herbal Dermals Ltd (Drugs)
- Jun 12, 2026FederalFTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
- Jun 11, 2026FederalFDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
- Jun 9, 2026OhioOH HB963: Revise the law governing the practice of physician assistants
- Jun 5, 2026GeorgiaGA State Medical Board: Gcmb Statement Regarding: IV Hydration/Therapy Position Statement | June 5, 2026
- May 27, 2026CaliforniaCA SB1089: Preventive Treatment Health Care Act.
- May 27, 2026FederalFDA recall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, Fl 34108, …
- May 26, 2026FederalPrimary Source Monitoring: Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Fo…
- May 19, 2026FederalPrimary Source Monitoring: California Doctor Convicted of $45M Botox Fraud Scheme Targeting Medicare
- May 19, 2026GeorgiaGA State Medical Board: IV Hydration/Therapy Position Statement
- May 12, 2026FederalFDA Warning Letter: Fresenius Kabi Compounding, LLC (Drugs)
- May 8, 2026FederalPrimary Source Monitoring: Med Spa Owner Pleads Guilty to Performing Illegal Injections Using Unapproved Prescription Drugs
- May 1, 2026FederalFDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act
- Apr 30, 2026FederalPrimary Source Monitoring: Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal
- Apr 23, 2026TennesseeTN HB2044: an Act to amend Tennessee Code Annotated, Title 63; Title 68, Chapter 11, Part 2 and Chapter 1042 of the Public Acts of 2024, relative to certified medical assistants.
- Apr 22, 2026FederalFDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
- Apr 22, 2026FederalFDA Warning Letter: Active Cosmetics Manufacturing Inc (Drugs)
- Apr 20, 2026FederalFDA Warning Letter: Foshan Miwei Cosmetics Co., Ltd. (Drugs)
- Apr 16, 2026FederalPrimary Source Monitoring: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for…
- Apr 9, 2026ConnecticutCT HB05399: An Act Concerning Dentistry.
- Apr 8, 2026MaineME LD2201: An Act to Implement Certain Recommendations Related to the Regulatory Review and Approval of Certain Health Care Transactions Involving Private Equity Companies, Hedge Funds or Management Services Organizations from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State
- Apr 7, 2026FederalPrimary Source Monitoring: Med Spa Owner Pleads Guilty to Performing Thousands of Injections Using Counterfeit Products
- Apr 2, 2026FederalFDA Warning Letter: Purolea Cosmetics Lab (Drugs)
- Apr 1, 2026FederalPrimary Source Monitoring: Utah Licensed Osteopathic Physician Indicted for Allegedly Receiving Misbranded Drugs from China and Selling them to Patients
- Apr 1, 2026FederalFDA Warning Letter: Pure Indulgence Aesthetics (Drugs)
- Mar 31, 2026FederalFDA Warning Letter: Gram Peptides (Drugs)
- Mar 31, 2026FederalFDA Warning Letter: Mile High Compounds (Drugs)
- Mar 27, 2026KentuckyKY HB885: an Act relating to cosmetology.
- Mar 18, 2026FederalFDA device recall (Class II): Clarity II Laser System; Model No. 1110200210.
- Mar 11, 2026FederalFDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
- Mar 11, 2026FederalFDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…
- Mar 11, 2026FederalFDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
- Mar 5, 2026IndianaIN SB0282: Compounding drugs; registration of medical spas.
- Mar 2, 2026West VirginiaWV SB486: Relating to Wv Board of Barbers and Cosmetologists
- Feb 23, 2026FederalPrimary Source Monitoring: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sectio…
- Feb 16, 2026West VirginiaWV HB5538: To expand licensing opportunities and safety regulation in the esthetics industry
- Feb 12, 2026Rhode IslandRI H7721: Establishes the Rhode Island Ban on the Corporate Practice of Medicine Act.
- Feb 10, 2026ArizonaAZ HB4047: Medical spas; licensure; regulation
- Jan 28, 2026HawaiiHI SB3195: Relating To Drugs For Weight Loss.
- Jan 28, 2026FederalFDA device recall (Class II): Brand Name: Leaseir Product Name: Leaseir Mhr Xcell Model/Catalog Number: Mhr 110-b Software Version: 1.5.0.0 Product D…
- Jan 27, 2026MassachusettsMA H5087: Regulating the operation of medical spas
- Jan 20, 2026IowaIA HSB591: A bill for an act establishing the medical spa oversight Act, and making penalties applicable.
- Jan 7, 2026FederalFDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
2025 · 26 changes
- Dec 18, 2025FederalPrimary Source Monitoring: Doctor Indicted for Orchestrating $45M Botox Fraud Scheme Targeting Medicare
- Dec 16, 2025PennsylvaniaPA HB1881: Further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.
- Dec 12, 2025FederalPrimary Source Monitoring: Med Spa Owner Agrees to Plead Guilty to Performing Illegal Injections Using Unapproved Prescription Drugs
- Dec 3, 2025FederalPrimary Source Monitoring: Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations
- Nov 5, 2025FederalFDA recall (Class II): Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
- Nov 5, 2025FederalFDA recall (Class II): Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
- Oct 15, 2025FederalFDA recall (Class II): Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca Raton…
- Oct 15, 2025FederalFDA recall (Class II): Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 20…
- Sep 10, 2025FederalFDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
- Aug 13, 2025FederalFDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
- Aug 13, 2025FederalFDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
- Jul 30, 2025FederalFDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2026
- Jul 2, 2025FederalFDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
- Jul 2, 2025FederalFDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80…
- Jun 30, 2025Rhode IslandRI H5351: Mandates cosmetic medical procedures be performed by a physician, PA, APRN, or delegated to a qualified non-physician, non-PA or non-APRN under the supervision of a physician, physician assistant, or advanced practice registered nurse.
- Jun 20, 2025TexasTX HB3749: Relating to the regulation of the provision of elective intravenous therapy.
- May 15, 2025TexasTX SB2696: Relating to the regulation of the performance of cosmetic injections; requiring an occupational certificate; authorizing fees.
- May 8, 2025TexasTX SB1117: Relating to the administration of botulinum toxin by dentists.
- May 7, 2025FederalFDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
- Apr 7, 2025ColoradoCO HB1024: Medical-Aesthetic Services Delegation Disclosures
- Mar 25, 2025North CarolinaNC S570: Prohibit the Corporate Practice of Medicine
- Feb 3, 2025OklahomaOK SB809: Physician assistants; allowing certain physician assistants to practice without supervision; specifying prescriptive authority. Effective date.
- Jan 21, 2025WashingtonWA SB5387: Concerning the corporate practice of medicine.
- Jan 14, 2025South CarolinaSC S0046: Healthcare contracts
- Jan 7, 2025FederalFDA / Federal Register Notice: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
- Jan 7, 2025FederalFDA / Federal Register Notice: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
2024 · 1 change
2023 · 1 change
- Mar 7, 2023South CarolinaSC H4084: Dental administration of neuromodulators
2021 · 1 change
Undated · 1 change
Regulatory monitoring, not legal, medical, or compliance advice. Every item links its primary source; verify there before acting. Legislative data via LegiScan (CC BY 4.0).
Get regulatory changes as they publish
We scan all 50 state legislatures daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address